Dolgin, E. Drugmakers go nuclear, continuing push into radiopharmaceuticals. Nat Biotechnol 39, 647–649 (2021). Radiotheranostics Tsunami! Interesting recent read about the growing clinical and financial interest in radiopharmaceuticals and radiotheranostics. After years of languishing attention, “there has been an explosion” of interest paid to the therapeutic strategy, says Chaitanya Divgi, a consultant and nuclear medicine specialist in Jenkintown, Pennsylvania. “Finally,” he says, “radiopharmaceuticals are getting the attention they deserve.” Read the article >>